Company intelligence

Bolt Biotherapeutics

Is something wrong on this page?

Recent changes

  1. Oct 25, 2026Bolt Biotherapeutics Buys Prana, Raises $120M For PRA-216 Pulse story
  2. Oct 24, 2026Acquired for $120M Pulse 2.0

Debt, IPO & other events

not counted in equity raised
DateEventAmountValuationInvestorsSource
Oct 24, 2026acquisition$120M—
Deep Track CapitalunverifiedAndreessen HorowitzunverifiedEventide Asset ManagementunverifiedCasdin CapitalunverifiedDeviation CapitalunverifiedADAR1 CapitalLYFE CapitalCoastlands CapitalCurie.Bio+3 more
Pulse 2.0

Investors

Latest Pulse

  1. Bolt Biotherapeutics Buys Prana, Raises $120M For PRA-216Bolt Biotherapeutics acquired Prana Therapies in a stock-for-stock reverse merger and raised a concurrent $120 million private placement to advance Prana's lead bispecific antibody, PRA-216.→

Coverage Timeline

newest first
  1. Oct 25, 2026FUNDINGBolt Biotherapeutics Buys Prana, Raises $120M For PRA-216$120M Placement→

All Coverage

Related Companies

Sources & methodologyshow
Where these figures come from

Figures are labelled Reported (a source states it), Estimated, Derived (computed from other facts) or Rumored (in talks / unconfirmed). Rumors never replace a confirmed figure. Each figure keeps its own as-of date; history is preserved rather than overwritten.

How we verify data ·